TrialCardiovascular diabetology2012

Effects of a vildagliptin/metformin combination on markers of atherosclerosis, thrombosis, and inflammation in diabetic patients with coronary artery disease.

Robert Klempfner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.